Free Trial

NKGen Biotech (NKGNW) SEC Filings & 10K Form

$0.09 0.00 (0.00%)
(As of 11/14/2024 ET)

Recent NKGen Biotech SEC Filings

DateFilerForm TypeView
10/30/2024
4:22 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:01 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
5:06 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
5:05 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
4:25 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:00 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
5:09 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:16 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/11/2024
4:26 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
6:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
7:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
5:45 PM
CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/22/2024
4:22 PM
CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Form SC 13G
08/22/2024
3:42 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
7:31 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form ARS
07/22/2024
4:19 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form DEF 14A
07/18/2024
4:52 PM
Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
4:53 PM
Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:25 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
7:15 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:58 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form PRER14A
07/12/2024
6:19 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
4:21 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 424B3
07/08/2024
11:15 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form EFFECT
06/27/2024
3:34 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form S-1/A
06/21/2024
3:14 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:54 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form S-1/A
05/13/2024
7:05 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
1:42 PM
METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Form SC 13G/A
04/29/2024
4:20 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 10-K/A
04/16/2024
2:07 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/11/2024
7:05 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
3:55 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
4:02 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:11 PM
Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:14 PM
Gagnon Pierre (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:16 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:19 PM
Kim Yong Man (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:20 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The next assassination attempt won’t be on Trump (Ad)

President Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person.

I share with you in this special investigative documentary.
02/14/2024
12:05 PM
METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Form SC 13G
02/14/2024
5:28 AM
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Radcliffe Capital Management, L.P. (Filed by)
Form SC 13G/A
02/12/2024
8:25 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
4:07 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:31 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
Form SC 13G/A
01/22/2024
5:12 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
6:50 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:19 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
3:14 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
12:41 PM
NKGen Biotech, Inc. (Subject)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKMAX Co., Ltd. (Filed by)
Form SC 13D/A
12/15/2023
8:02 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKMAX Co., Ltd. (Reporting)
Park Sangwoo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:44 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form S-1/A
12/07/2023
4:23 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
2:50 PM
Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
2:51 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
4:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form S-1/A
11/22/2023
4:53 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:55 PM
Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
3:36 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:39 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NKGNW) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners